|
NDRA ENDRA Life Sciences Inc 1681682 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,311,433.00 |
| Balance Sheet |
|
Current Assets
|
$536,666.00 |
|
Assets
|
$3,438,182.00 |
|
Current Liabilities
|
$835,440.00 |
|
Liabilities
|
$1,651,297.00 |
|
Equity
|
$1,786,885.00 |
|
Shares Out
|
1240751.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,119,650.00 |
|
Investing Cash Flow
|
$450,000.00 |
| Market Analysis |
Market Cap
|
$5,372,451.83 |
|
Price
|
$4.50 |
|
BVPS
|
1.44 |
|
PB
|
3.01 |
|
EPS
|
-1.09 |
|
FCF
|
$-1,136,930.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:45 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NDRA documents filed with the SEC.
NDRA Filings
Clear
